Editor’s Note: It should come as no surprise that at some point the use of blood would become the latest craze among those seeking to overcome the aging process common to all under the curse of sin…ultimately resulting in physical death. What may have started out with anti-aging skin products using tissue from murdered unborn babies to today, live blood transfusions from young people. Surely, Evolutionary Darwinianism (no god, morality is relative) plays a major role in such acts of mankind with its mantra of “Survival of the Fittest.”
As Romans clearly reveals…man will become inventors of evil:
28 And since they did not see fit to acknowledge God, God gave them up to a debased mind to do what ought not to be done. 29 They were filled with all manner of unrighteousness, evil, covetousness, malice. They are full of envy, murder, strife, deceit, maliciousness. They are gossips, 30 slanderers, haters of God, insolent, haughty, boastful, inventors of evil, disobedient to parents, 31 foolish, faithless, heartless, ruthless. 32 Though they know God’s righteous decree that those who practice such things deserve to die, they not only do them but give approval to those who practice them.
~ Romans 1:28-32
[The End of the American Dream] If it would add a decade to your life, would you allow the blood of young people to be injected into your veins? I understand that this may sound very strange to you, but the truth is that interest in this sort of “anti-aging therapy” has surged among the elite in recent years. And now a company called Ambrosia has opened clinics in five major U.S. cities where you can actually have “youthful blood” injected directly into your veins. But it isn’t cheap. According to Jesse Karmazin, the founder of Ambrosia, having one liter of young blood injected into you will cost $8,000 and getting two liters of young blood will set you back $12,000:
The company is now up and running, Karmazin told Business Insider on Wednesday. Ambrosia recently revamped its websitewith a list of clinic locations and is now accepting payments for the procedure via PayPal. Two options are listed: 1 liter of young blood for $8,000, or 2 liters for $12,000.
In the fall, Karmazin — who is not a licensed medical practitioner — told Business Insider he planned to open the first Ambrosia clinic in New York City by the end of the year. That didn’t happen. Instead, he said, the sites where customers can get the procedure include Los Angeles; San Francisco; Tampa, Florida; Omaha, Nebraska; and Houston, Texas.
Since these “treatments” are so expensive, for now it will only be the wealthy that will be able to afford them.
But apparently there is a lot of interest, because the company actually had to create a waiting list because there was so much demand.
You might be tempted to think that something like this must be illegal, but it isn’t. In essence, these “treatments” are basically just blood transfusions, and therefore no special permission from the FDA is required.
The potential health benefits of young blood is something that has fascinated researchers for centuries, but it was a field of study that was relatively dormant until “around the turn of the millennium”:
Then around the turn of the millennium, a professor who’d learned about parabiosis in Montana in the 1950s passed on his knowledge of the procedure to a grad student, whose work created a new academic lineage probing young blood. (Some researchers hope it could help to turn back the effects of aging, others just hope it could help the elderly recover from injuries or people of all ages undergo treatments like chemotherapy.) These new researchers established that its potential benefits lie in the fact that as we age, the levels of some of the 700 or so proteins in our blood plasma shift, causing rippling changes in all of our tissues and bodily functions. (Hence old blood can theoretically cause aging effects in a younger body, just as young blood’s proteins can rejuvenate, although not reverse aging, in older folks.)
And over the past several years the backing of prominent elitists such as billionaire tech investor Peter Thiel has pushed this “technology” to the forefront:
Over the summer it became apparent that Silicon Valley wingnut Peter Thiel was fascinated with the prospect of extending his life by transfusing the blood of younger humans into his veins. This revelation (although not shocking given Thiel’s notorious oddities and obsession with fringe elixirs) touched off a storm of cheap vampire-joke headlines. But it also put a spotlight on the trove of research that sparked Thiel’s literal bloodlust—studies showing that mice infused with the blood of their youngers experienced signs of rejuvenation and statistically longer lives.
But does it actually work?
Ambrosia conducted a “clinical trial” in 2017, but they have not released the results yet.
[Editor’s Note: This article was written by Michael Snyder and originally published at The End of the American Dream.]
[Editor’s Note: Title changed by P&P.]
